Digestive enzymes and stomach acid can break down peptides before they are fully absorbed, which reduces the amount that reaches target tissues
Most-referenced community reconstitution: 2 mL BAC water
Example 1: Athlete annual plan Off-season (Months 1-4) : Build Ipamorelin + CJC-1295 full protocol BPC-157 for injury prevention Focus: Maximum muscle/strength gains Cost : $800-1,200 Pre-season (Months 5-6) : Transition Reduce GH peptides to 3x weekly Continue BPC-157 Focus: Maintain gains, prepare for competition Cost : $300-500 In-season (Months 7-10) : Perform BPC-157 only (recovery + injury prevention) Add TB-500 if minor injuries occur Focus: Recovery, injury management Cost : $400-800 Post-season (Months 11-12) : Recover BPC-157 + TB-500 stack for any accumulated damage Rest from GH peptides Focus: Healing, reset Cost : $300-600 Annual cost : $1,800-3,100 Adjustments : Add peptides as needed for specific issues Example 2: Weight loss to body recomposition Phase 1 (Months 1-5) : Major weight loss Semaglutide full protocol 30-40 lbs weight loss Cost : $650-1,100 Phase 2 (Months 6-7) : Transition Taper semaglutide to maintenance Start Ipamorelin for muscle preservation Increase calories gradually Cost : $400-650 Phase 3 (Months 8-12) : Muscle building Ipamorelin + CJC-1295 full protocol Calorie surplus, progressive training 8-12 lbs muscle gain Cost : $1,000-1,600 Annual cost : $2,050-3,350 Results : 30-40 lbs fat lost, 8-12 lbs muscle gained, completely transformed body composition Example 3: Comprehensive longevity protocol All 12 months continuous : Ipamorelin + CJC-1295 (GH optimization) NAD+ peptides (mitochondrial support) GHK-Cu (skin + inflammation) BPC-157 added as needed for any issues Monthly cost : $500-800 Annual cost : $6,000-9,600 Expected results : Optimal aging markers, maintained vitality, excellent recovery, sustained energy Blood work schedule : Every 3 months Adjustments : Reduce/increase individual peptides based on results and blood work Use our peptide cost calculator for exact budgeting
an FDA advisory committee rejected adding it to the approved compounding list in 2024, citing toxicity and an unresolved cardiac signal
Fascial manipulation and dry needling to restore fascias functional properties and reduce load on the knees
